Az. Anadol et al., ROLE OF ENDOGENOUS ENDOTHELIN PEPTIDES IN INTESTINAL ISCHEMIA-REPERFUSION INJURY IN RATS, Prostaglandins, leukotrienes and essential fatty acids, 59(4), 1998, pp. 279-283
In this study, the effects of BQ123 tan ETA receptor antagonist), bose
ntan (a nonselective ETA-ETB antagonist), and phosphoramidon tan endot
helin converting enzyme inhibitor) were investigated on intestinal muc
osal lesion formation and changes in tissue PGE(2) and LTC4 levels due
to intestinal ischemia-reperfusion (I/R) injury in rats. Following 30
min of ischemia, the substances were given via the inferior caval vei
n, and 10 min later the intestine was subjected to reperfusion for 30
min. The intestinal specimens were evaluated both microscopically and
the tissue PGE(2) and LTC4 levels were obtained for each group. The hi
stopathologic examination revealed a significant reduction in tissue i
njury in both BQ123 and phosphoramidon pretreated groups compared with
the control group. Bosentan, on the contrary, did not decrease the in
jury. The pharmacologic examination revealed a significant reduction o
f PGE(2)-like activity in both BQ123 and phosphoramidon pretreated gro
ups, compared with the control group, while LTC4-like activity remaine
d unchanged except for an increase in the bosentan pretreated group.